Subscribe
Machinery & Materials
Markets
Logistics & Cold Chain
Issues
Events
Newsletters
Johnson & Johnson
More from Johnson & Johnson
Home
Counting Down the Top 10 articles of 2019 - #10: J&J on E-Comm
Based on our online clicks and unique page views, we're counting down the Top 10 articles of 2019. Over these final 10 days of the year, join us as we look back at the best of 2019. At #10 is this article about J&J's e-comm strategy.
Nutraceuticals/functional
FDA Finds Asbestos in Baby Powder, Recall Ensues
Johnson & Johnson recalled thousands bottles of their famous baby powder after the FDA found trace amounts of asbestos.
Sustainability
At J&J Consumer, Packaging is a Team Sport
Millennials, sustainable packaging, speed to market, e-commerce, and keeping up with nimble competitors—packaging professionals at J&J Consumer are laser focused on all of the above.
Home
Johnson’s Baby Brand Gets Global Restaging
Known all over the world as the brand parents trust when it comes to baby health and wellness, Johnson’s Baby just went through a reset that included a 70% reduction in the number of bottle and closure styles.
Regulatory
J&J to Pay Record Amount in Talcum Powder Suit
A Missouri jury ordered Johnson & Johnson to pay out billions to women claiming their talc-based products contained asbestos and caused cancer.
Pharmaceutical
Johnson & Johnson Supply Chain (JJSC) Employs Global Serialization Strategy
With a heritage of 130+ years of helping people live longer lives, JJSC’s serialization/traceability efforts focus on safely delivering medicines to healthcare providers and patients worldwide.
Medical device packaging
FDA Approves Transition Contact Lenses
After 10 year of development, the FDA has approved Johnson & Johnson’s contact lenses that darken in sunlight.
Pharmaceutical
Researchers Test New HIV Vaccine and Long-Acting Drug in Africa
A three-year vaccine trial marks the first time in over a decade that two HIV vaccine trials have occurred simultaneously.
Pharmaceutical
New and Improved Pneumonia Vaccine in Development
University at Buffalo researchers are developing a new pneumonia vaccine that addresses antimicrobial issues.
